Litman Gregory Wealth Management LLC Sells 220 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Litman Gregory Wealth Management LLC lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% during the 4th quarter, Holdings Channel reports. The firm owned 22,946 shares of the healthcare conglomerate’s stock after selling 220 shares during the quarter. UnitedHealth Group comprises approximately 1.1% of Litman Gregory Wealth Management LLC’s investment portfolio, making the stock its 21st largest holding. Litman Gregory Wealth Management LLC’s holdings in UnitedHealth Group were worth $12,080,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of UNH. Robbins Farley bought a new position in UnitedHealth Group in the third quarter worth approximately $25,000. Richelieu Gestion SA bought a new stake in UnitedHealth Group during the 4th quarter valued at $26,000. CGC Financial Services LLC boosted its position in UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 50 shares in the last quarter. NewSquare Capital LLC boosted its position in UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 51 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA boosted its position in UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after acquiring an additional 40 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded up $8.11 during trading on Friday, reaching $501.29. 6,616,632 shares of the company traded hands, compared to its average volume of 4,553,088. The firm’s fifty day simple moving average is $488.63 and its 200 day simple moving average is $515.13. The stock has a market cap of $462.16 billion, a P/E ratio of 30.64, a PEG ratio of 1.31 and a beta of 0.54. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company’s revenue was up 8.6% on a year-over-year basis. During the same quarter last year, the business posted $6.26 EPS. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 27.74 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.50%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

Insider Activity

In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on UNH shares. Royal Bank of Canada dropped their target price on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research report on Wednesday. Truist Financial reaffirmed a “buy” rating and set a $600.00 target price on shares of UnitedHealth Group in a research report on Wednesday. Piper Sandler increased their price objective on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a report on Wednesday. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday. Finally, Morgan Stanley decreased their price objective on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday, April 5th. Four analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $570.05.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.